(257) The 40-gene expression profile (40-GEP) test stratifies metastatic risk in high-risk cutaneous squamous cell carcinoma (cSCC) cases where uncertainty in differentiation status would impact risk assessment

Sarah Estrada, MD; Jennifer Siegel, PhD; Alison Fitzgerald, PhD; Anesh Prasai, PhD; Matthew Goldberg, MD; Aaron Farberg, MD & Sherrif Ibrahim, MD/PhD

ASDP 60th Annual Meeting

Part of: Poster Defense Session